Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Cancer immunotherapy via dendritic cells
Extracellular vesicles–vehicles that spread cancer genes
Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial
Dendritic cells the tumor microenvironment and the challenges for an effective antitumor vaccination
Immunotherapy using dendritic cells against multiple myeloma: how to improve?
Newcastle disease virus triggers autophagy in U251 glioma cells to enhance virus replication
Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice
Prostate cancer vaccines: moving therapeutic vaccination forward in the post-Provenge era
Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions
Clinical and immunologic evaluation of dendritic cell-based immunotherapy in combination with gemcitabine and/or S-1 in patients with advanced pancreatic carcinoma
Clinical utilization of postoperative dendritic cell vaccine plus activated T-cell transfer in patients with intrahepatic cholangiocarcinoma
Virotherapy of neuroendocrine tumors
Targeting pediatric cancer stem cells with oncolytic virotherapy
Sodium arsenite ± hyperthermia sensitizes p53-expressing human ovarian cancer cells to cisplatin by modulating platinum-DNA damage responses
Quality of life during dendritic cell vaccination against metastatic renal cell carcinoma
HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situ
Newcastle disease virus LaSota strain kills human pancreatic cancer cells in vitro with high selectivity
Immunotherapy for metastatic colorectal cancer: present status and new options
The dermis as a portal for dendritic cell-targeted immunotherapy of cutaneous melanoma
Clinical application of a dendritic cell vaccine raised against heat-shocked glioblastoma